PB1908: COVID-19 INSIGHTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: DIAGNOSIS AND TREATMENT

PB1908: COVID-19 INSIGHTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: DIAGNOSIS AND TREATMENT

Bibliographic Details
Main Author:	V. Musteata
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000850484.31704.89

Similar Items

PB1965: INSIGHTS INTO RELAPSED AND REFRACTORY CHRONIC MYELOID LEUKEMIA: MOLECULAR-GENETIC, BIOCHEMICAL AND PROGNOSIS PATTERNS
by: Vasile Musteata
Published: (2023-08-01)

COVID-19 in patients with chronic myeloid leukemia: management challenges and outcomes
by: Vasile MUSTEATA
Published: (2021-12-01)

TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: MANAGEMENT APPROACHES
by: Vasile Musteata
Published: (2022-10-01)

PB1900: COVID-19 IMPACT ON CHRONIC MYELOID LEUKEMIA PATIENTS
by: S.-M. Galdean, et al.
Published: (2022-06-01)

PB1908: NRF2 INHIBITION IN COMBINATION WITH IBRUTINIB IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA– AN IN VITRO STUDY
by: Joana Jorge, et al.
Published: (2023-08-01)

Standards for the diagnosis and treatment of chronic myeloid leukemia
by: Paulo Campregher
Published: (2018-04-01)

COVID-19 Impact on Chronic Myeloid Leukemia Patients
by: Dana Raluca Arbore, et al.
Published: (2022-11-01)

COVID-19 IN CHRONIC MYELOID LEUKEMIA PATIENTS – BRAZILIAN EXPERIENCE
by: K.B.B. Pagnano, et al.
Published: (2020-11-01)

COVID-19 IN CHRONIC MYELOID LEUKEMIA PATIENTS – BRAZILIAN EXPERIENCE
by: KBB Pagnano, et al.
Published: (2021-10-01)

Chronic lymphocytic leukemia: diagnostic profile and treatment outcomes
by: L. Musteata, et al.
Published: (2020-09-01)

PB1905: FEASIBILITY OF TREATMENT DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA IN CLINICAL PRACTICE: RESULTS FROM A SERIES OF 19 PATIENTS
by: F. KACHA, et al.
Published: (2022-06-01)

PB1910: CHRONIC MYELOID LEUKEMIA AND RELATIONSHIP TO SECONDARY SOLID NEOPLASMS
by: M. J. Ramos, et al.
Published: (2022-06-01)

PB1969: PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND CORONAVIRUS DISEASE 2019 IN THE OMICRON ERA
by: Feiyang Qi, et al.
Published: (2023-08-01)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
by: Ann-Marie Leahey, et al.
Published: (2021-01-01)

Advances in the treatment of chronic myeloid leukemia
by: Morley Kimberly, et al.
Published: (2011-08-01)

PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE
by: Y. Bouchakor Moussa, et al.
Published: (2022-06-01)

PB1975: ABL1 GENE DNA SEQUENCING IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND PH+ ACUTE LYMPHOBLASTIC LEUKEMIA.
by: Elena Kuzmina, et al.
Published: (2023-08-01)

Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment
by: Alessia Castellino, et al.
Published: (2021-10-01)

Chromosomal Instability in Chronic Myeloid Leukemia: Mechanistic Insights and Effects
by: Jayastu Senapati, et al.
Published: (2022-05-01)

New insights into antigen specific immunotherapy for chronic myeloid leukemia
by: Li Yangqiu, et al.
Published: (2012-12-01)

Acute Myeloid Leukemia: Advancements in Diagnosis and Treatment
by: Meng-Ge Yu, et al.
Published: (2017-01-01)

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis
by: Ester M. Orlandi, et al.
Published: (2015-01-01)

PB1870: COVID - 19 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: HOSPITAL MORALITY PREDICTORS
by: O. Kochneva, et al.
Published: (2022-06-01)

Chronic myeloid leukemia
by: Susanne Sauβele
Published: (2018-06-01)

Chronic myeloid leukemia
by: Oliver Hantschel, (Coordinating Author)
Published: (2019-06-01)

Imatinib Mesylate Treatment in Chronic Myeloid Leukemia
by: Demet Çekdemir, et al.
Published: (2020-03-01)

Editorial: Advances in the treatment of chronic myeloid leukemia
by: Ahmet Emre Eşkazan, et al.
Published: (2023-03-01)

Optimized Treatment Schedules for Chronic Myeloid Leukemia.
by: Qie He, et al.
Published: (2016-10-01)

Is karyotyping still needed in the diagnosis and monitoring of chronic myeloid leukemia?
by: Maria de Lourdes L.F. Chauffaille

THE ROLE OF CYTOGENETICS AND MOLECULAR GENETICS IN DIAGNOSIS OF CHRONIC MYELOID LEUKEMIA AND MONITORING OF TREATMENT RESPONSE
by: Helena Podgornik, et al.
Published: (2004-12-01)

PB1837: ANTIBIOTICS; A POSSIBLE ALTERNATE TREATMENT OPTION FOR MYELOID LEUKEMIA
by: Syeda Maham, et al.
Published: (2023-08-01)

Impact of the COVID-19 pandemic on the regular follow-up and outcomes of patients with chronic myeloid leukemia in chronic-phase
by: Umut Yılmaz, et al.
Published: (2022-10-01)

COVID-19 in Chronic-Phase Chronic Myeloid Leukemia Patients: A Single-Center Survey from Turkey
by: Umut Yılmaz, et al.
Published: (2021-02-01)

Acute myeloid leukemia: update in diagnosis and treatment in Brazil
by: Ricardo Helman, et al.
Published: (2011-06-01)

Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia
by: Carolina Alarcón-Payer, et al.
Published: (2022-09-01)

PB1986: FIRST-LINE TREATMENT OUTCOMES OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IN A REAL-WORLD DATA SETTING IN LEBANON
by: Lewis Nasr, et al.
Published: (2023-08-01)

Treatment-free remission in patients with chronic myeloid leukemia: literature review
by: A. N. Petrova, et al.
Published: (2019-10-01)

Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations
by: Keskin D, et al.
Published: (2016-10-01)

Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia
by: S V Gritsaev, et al.
Published: (2016-07-01)

Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
by: A. K. Golenkov, et al.
Published: (2014-07-01)